
Sign up to save your podcasts
Or


The House Rules Committee takes up a bipartisan CR. The CEO of Novo Nordisk testifies Tuesday about Ozempic and Wegovy prices. And lawmakers look ahead to potential farm bill action during the lame-duck session. David Higgins has your CQ Morning Briefing for Monday, Sept. 23, 2024.
By CQ Roll Call4.3
1313 ratings
The House Rules Committee takes up a bipartisan CR. The CEO of Novo Nordisk testifies Tuesday about Ozempic and Wegovy prices. And lawmakers look ahead to potential farm bill action during the lame-duck session. David Higgins has your CQ Morning Briefing for Monday, Sept. 23, 2024.

1,380 Listeners

270 Listeners

60 Listeners

30 Listeners

1,523 Listeners

707 Listeners

6,304 Listeners

113,121 Listeners

2,380 Listeners

7,244 Listeners

141 Listeners

386 Listeners

16,525 Listeners

718 Listeners

747 Listeners